Maryland | 001-33202 | 52-1990078 | ||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
1020 Hull Street, Baltimore, Maryland | 21230 | |||
(Address of principal executive offices) | (Zip Code) |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
(a) | provide that each share of Class B Common Stock will automatically convert into one share of Class A Common Stock if Kevin Plank (the Company’s founder and Chairman of the Board and Chief Executive Officer) sells, or otherwise disposes of, more than a specified number of shares of the Company’s common stock in any calendar year; |
For | Against | Abstain |
468,871,924 | 463,895 | 244,952 |
(b) | provide that each share of Class B Common Stock will automatically convert into one share of Class A Common Stock if Mr. Plank resigns from the Company or his employment with the Company is terminated for cause; |
For | Against | Abstain |
468,872,807 | 462,117 | 245,847 |
(c) | provide for the treatment of shares of Class A Common Stock in a manner that is at least as favorable as shares of Class B Common Stock in certain merger, consolidation, statutory share exchange, conversion and negotiated tender offer transactions (the “Equal Treatment Provision”); |
For | Against | Abstain |
468,967,952 | 367,796 | 245,023 |
(d) | enhance board independence requirements for so long as the Class B Common Stock is outstanding by (1) prohibiting the Company from availing itself of the exemptions for “controlled companies” under stock exchange listing standards and (2) imposing stricter standards for determining whether directors are “independent” (the “Board Independence Provisions”); and |
For | Against | Abstain |
467,850,951 | 349,131 | 1,380,689 |
(e) | provide that the Equal Treatment Provision and the Board Independence Provisions cannot be amended unless declared advisable by the Board of Directors of the Company, including at least 75% of the independent members of the Board, and approved by the affirmative vote of at least 75% of the votes entitled to be cast thereon by holders of (1) the Class A Common Stock (other than Mr. Plank, his family entities, his family members or any executive officer of the Company), voting as a single class, and (2) the Class B Common Stock, voting as a single class. |
For | Against | Abstain |
468,546,623 | 783,245 | 250,903 |
For | Against | Abstain |
416,054,364 | 52,108,654 | 1,417,753 |
For | Against | Abstain |
455,046,401 | 13,135,178 | 1,399,192 |
UNDER ARMOUR, INC. | ||||
Date: September 1, 2015 | By: | /s/ JOHN P. STANTON | ||
John P. Stanton | ||||
Senior Vice President, General Counsel & Secretary |